Taiwan · Delayed Price · Currency is TWD DV Biomed Statistics
Total Valuation
DV Biomed has a market cap or net worth of TWD 1.24 billion. The enterprise value is 957.10 million.
| Market Cap | 1.24B |
| Enterprise Value | 957.10M |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
DV Biomed has 24.35 million shares outstanding.
| Current Share Class | 24.35M |
| Shares Outstanding | 24.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.88% |
| Owned by Institutions (%) | n/a |
| Float | 3.60M |
Valuation Ratios
The trailing PE ratio is 160.19.
| PE Ratio | 160.19 |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 42.23 |
| P/OCF Ratio | 21.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.04, with an EV/FCF ratio of 32.61.
| EV / Earnings | 123.70 |
| EV / Sales | 1.21 |
| EV / EBITDA | 19.04 |
| EV / EBIT | 64.43 |
| EV / FCF | 32.61 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.55 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.91 |
| Debt / FCF | 1.55 |
| Interest Coverage | 9.90 |
Financial Efficiency
Return on equity (ROE) is 1.55% and return on invested capital (ROIC) is 5.28%.
| Return on Equity (ROE) | 1.55% |
| Return on Assets (ROA) | 1.28% |
| Return on Invested Capital (ROIC) | 5.28% |
| Return on Capital Employed (ROCE) | 2.75% |
| Weighted Average Cost of Capital (WACC) | 5.35% |
| Revenue Per Employee | 2.44M |
| Profits Per Employee | 23,733 |
| Employee Count | 326 |
| Asset Turnover | 1.09 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, DV Biomed has paid 2.02 million in taxes.
| Income Tax | 2.02M |
| Effective Tax Rate | 19.99% |
Stock Price Statistics
The stock price has decreased by -6.89% in the last 52 weeks. The beta is 0.22, so DV Biomed's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -6.89% |
| 50-Day Moving Average | 54.89 |
| 200-Day Moving Average | 56.37 |
| Relative Strength Index (RSI) | 38.78 |
| Average Volume (20 Days) | 3,645 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DV Biomed had revenue of TWD 794.18 million and earned 7.74 million in profits.
| Revenue | 794.18M |
| Gross Profit | 566.63M |
| Operating Income | 14.86M |
| Pretax Income | 10.11M |
| Net Income | 7.74M |
| EBITDA | 50.28M |
| EBIT | 14.86M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 327.79 million in cash and 45.51 million in debt, with a net cash position of 282.28 million or 11.59 per share.
| Cash & Cash Equivalents | 327.79M |
| Total Debt | 45.51M |
| Net Cash | 282.28M |
| Net Cash Per Share | 11.59 |
| Equity (Book Value) | 507.37M |
| Book Value Per Share | n/a |
| Working Capital | 351.35M |
Cash Flow
In the last 12 months, operating cash flow was 57.50 million and capital expenditures -28.15 million, giving a free cash flow of 29.35 million.
| Operating Cash Flow | 57.50M |
| Capital Expenditures | -28.15M |
| Depreciation & Amortization | 35.42M |
| Net Borrowing | -21.57M |
| Free Cash Flow | 29.35M |
| FCF Per Share | 1.21 |
Margins
Gross margin is 71.35%, with operating and profit margins of 1.87% and 0.97%.
| Gross Margin | 71.35% |
| Operating Margin | 1.87% |
| Pretax Margin | 1.27% |
| Profit Margin | 0.97% |
| EBITDA Margin | 6.33% |
| EBIT Margin | 1.87% |
| FCF Margin | 3.70% |
Dividends & Yields
This stock pays an annual dividend of 2.37, which amounts to a dividend yield of 4.66%.
| Dividend Per Share | 2.37 |
| Dividend Yield | 4.66% |
| Dividend Growth (YoY) | -74.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 480.08% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.66% |
| Earnings Yield | 0.62% |
| FCF Yield | 2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2025. It was a forward split with a ratio of 1.18.
| Last Split Date | Aug 28, 2025 |
| Split Type | Forward |
| Split Ratio | 1.18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |